Clinical Trials

NCT06751329 | RECRUITING | PHASE1/PHASE2
280 participants

A Study of DM002 in Patients With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2025-02-17
Completion:
2027-10-08
Conditions
  • Ovarian Neoplasms
  • Prostatic Neoplasms
  • Endometrial Neoplasms
  • Colorectal Neoplasms
  • Solid Carcinoma
  • Pancreatic Cancer
Interventions
  • DRUG
No Results Yet
NCT06687226 | NOT_YET_RECRUITING | NA
20 participants

Food DNA Digestion

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2027-01-01
Completion:
2027-12-01
Conditions
  • Digestion Rate
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT06651333 | RECRUITING
240 participants

fMRI and Opioid Abstinence

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-07
Start Date:
2024-12-12
Completion:
2029-11-30
Conditions
  • Drug Use Disorder
  • Opioid Dependence
  • Opioid-Related Disorders
  • Opioid Use
  • Opioid Abuse
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT06649812 | RECRUITING | PHASE2
120 participants

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-07
Start Date:
2025-10-07
Completion:
2027-09-01
Conditions
  • High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page